Dina Appleby

2.4k total citations · 1 hit paper
32 papers, 1.7k citations indexed

About

Dina Appleby is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Dina Appleby has authored 32 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Public Health, Environmental and Occupational Health and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Dina Appleby's work include Pulmonary Hypertension Research and Treatments (10 papers), Preterm Birth and Chorioamnionitis (4 papers) and Assisted Reproductive Technology and Twin Pregnancy (3 papers). Dina Appleby is often cited by papers focused on Pulmonary Hypertension Research and Treatments (10 papers), Preterm Birth and Chorioamnionitis (4 papers) and Assisted Reproductive Technology and Twin Pregnancy (3 papers). Dina Appleby collaborates with scholars based in United States, Switzerland and Canada. Dina Appleby's co-authors include Myles Wolf, Raymond R. Townsend, Huiliang Xie, L. Lee Hamm, Jing Chen, Gabriela Vargas, Cheryl A.M. Anderson, Tamara Isakova, Chi‐yuan Hsu and Lisa Nessel and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, The Journal of Comparative Neurology and Kidney International.

In The Last Decade

Dina Appleby

30 papers receiving 1.7k citations

Hit Papers

Fibroblast growth factor 23 is elevated before parathyroi... 2011 2026 2016 2021 2011 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
    2011 917 citations Tamara Isakova, Patricia Wahl et al. Kidney International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dina Appleby United States 15 870 330 326 270 257 32 1.7k
Christine Simpson United States 19 342 0.4× 173 0.5× 167 0.5× 229 0.8× 115 0.4× 49 1.3k
Aida Lteif United States 27 148 0.2× 65 0.2× 352 1.1× 148 0.5× 148 0.6× 71 2.1k
Dalit Modan‐Moses Israel 25 90 0.1× 98 0.3× 235 0.7× 139 0.5× 191 0.7× 85 1.7k
Silvia Lai Italy 19 299 0.3× 49 0.1× 120 0.4× 61 0.2× 74 0.3× 104 1.1k
Neville J. Howard Australia 26 208 0.2× 92 0.3× 910 2.8× 72 0.3× 102 0.4× 47 2.0k
Hilary F. Luderer United States 13 84 0.1× 479 1.5× 185 0.6× 1.2k 4.3× 202 0.8× 21 1.7k
Assimina Galli‐Τsinopoulou Greece 22 95 0.1× 207 0.6× 346 1.1× 31 0.1× 156 0.6× 111 1.5k
Hyun Wook Chae South Korea 21 71 0.1× 114 0.3× 317 1.0× 105 0.4× 316 1.2× 133 1.8k
Nicola Crabtree United Kingdom 23 91 0.1× 112 0.3× 118 0.4× 199 0.7× 247 1.0× 64 1.9k
Ayşe Balat Türkiye 18 144 0.2× 60 0.2× 102 0.3× 52 0.2× 117 0.5× 99 1.1k

Countries citing papers authored by Dina Appleby

Since Specialization
Citations

This map shows the geographic impact of Dina Appleby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Appleby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Appleby more than expected).

Fields of papers citing papers by Dina Appleby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dina Appleby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Appleby. The network helps show where Dina Appleby may publish in the future.

Co-authorship network of co-authors of Dina Appleby

This figure shows the co-authorship network connecting the top 25 collaborators of Dina Appleby. A scholar is included among the top collaborators of Dina Appleby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dina Appleby. Dina Appleby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Naamani, Nadine, Jasleen Minhas, Jason S. Fritz, et al.. (2025). Renal dysfunction and outcomes in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: an individual participant data meta-analysis. European Respiratory Journal. 66(2). 2402400–2402400.
2.
Minhas, Jasleen, Jude Moutchia, Nadine Al‐Naamani, et al.. (2024). Electrocardiographic Abnormalities and Their Association with Outcomes in Randomized Clinical Trials of Pulmonary Arterial Hypertension. Annals of the American Thoracic Society. 21(6). 858–865. 1 indexed citations
3.
Blette, Bryan S., Jude Moutchia, Nadine Al‐Naamani, et al.. (2023). Is low-risk status a surrogate outcome in pulmonary arterial hypertension? An analysis of three randomised trials. The Lancet Respiratory Medicine. 11(10). 873–882. 14 indexed citations
4.
Moutchia, Jude, Robyn L. McClelland, Nadine Al‐Naamani, et al.. (2023). Minimal Clinically Important Difference in the 6-minute-walk Distance for Patients with Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 207(8). 1070–1079. 36 indexed citations
5.
McClelland, Robyn L., Jude Moutchia, Dina Appleby, et al.. (2023). Heterogeneity of treatment effects by risk in pulmonary arterial hypertension. European Respiratory Journal. 62(1). 2300190–2300190. 5 indexed citations
6.
Ventetuolo, Corey E., Jude Moutchia, Grayson L. Baird, et al.. (2022). Baseline Sex Differences in Pulmonary Arterial Hypertension Randomized Clinical Trials. Annals of the American Thoracic Society. 20(1). 58–66. 12 indexed citations
7.
Lai, H. Henry, Craig Newcomb, Dina Appleby, et al.. (2021). Comparison of deep phenotyping features of UCPPS with and without Hunner lesion: A MAPP‐II Research Network Study. Neurourology and Urodynamics. 40(3). 810–818. 14 indexed citations
8.
Min, Jeff, Dina Appleby, Robyn L. McClelland, et al.. (2021). Secular and Regional Trends among Pulmonary Arterial Hypertension Clinical Trial Participants. Annals of the American Thoracic Society. 19(6). 952–961. 15 indexed citations
9.
Kornfield, Sara L., et al.. (2017). Posttraumatic Symptom Reporting and Reported Cigarette Smoking During Pregnancy. Journal of Women s Health. 26(6). 662–669. 8 indexed citations
10.
Shanmugan, Sheila, James Loughead, Ravi Prakash Reddy Nanga, et al.. (2016). Lisdexamfetamine Effects on Executive Activation and Neurochemistry in Menopausal Women with Executive Function Difficulties. Neuropsychopharmacology. 42(2). 437–445. 21 indexed citations
11.
Volpp, Kevin G., Andrea B. Troxel, Judith A. Long, et al.. (2015). A randomized controlled trial of co-payment elimination: the CHORD trial.. PubMed. 21(8). e455–64. 8 indexed citations
12.
Epperson, C. Neill, Sheila Shanmugan, Deborah R. Kim, et al.. (2015). New onset executive function difficulties at menopause: a possible role for lisdexamfetamine. Psychopharmacology. 232(16). 3091–3100. 34 indexed citations
13.
Appleby, Dina, et al.. (2015). Placental Transfer of Antidepressant Medications: Implications for Postnatal Adaptation Syndrome. Clinical Pharmacokinetics. 54(4). 359–370. 64 indexed citations
14.
Drawz, Paul E., Denise C. Babineau, Carolyn Brecklin, et al.. (2013). Heart Rate Variability Is a Predictor of Mortality in Chronic Kidney Disease: A Report from the CRIC Study. American Journal of Nephrology. 38(6). 517–528. 77 indexed citations
15.
Wan, Fei, et al.. (2013). Quality of embryos transferred and progesterone levels are the most important predictors of live birth after fresh embryo transfer: a retrospective cohort study. Journal of Assisted Reproduction and Genetics. 31(2). 185–194. 23 indexed citations
16.
Motsinger‐Reif, Alison A., Hongjie Zhu, Mitchel A. Kling, et al.. (2013). Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer’s disease from normal cognitive aging. Acta Neuropathologica Communications. 1(1). 28–28. 47 indexed citations
17.
Shaunik, Alka, Jennifer L. Kulp, Dina Appleby, Mary D. Sammel, & Kurt T. Barnhart. (2011). Utility of dilation and curettage in the diagnosis of pregnancy of unknown location. American Journal of Obstetrics and Gynecology. 204(2). 130.e1–130.e6. 32 indexed citations
18.
Isakova, Tamara, Patricia Wahl, Gabriela Vargas, et al.. (2011). Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney International. 79(12). 1370–1378. 917 indexed citations breakdown →
19.
Srinivas, Sindhu K., Jacob Larkin, Mary D. Sammel, et al.. (2010). The use of angiogenic factors in discriminating preeclampsia: are they ready for prime time?. The Journal of Maternal-Fetal & Neonatal Medicine. 23(11). 1294–1300. 11 indexed citations
20.
Gómez, Luis M., Mary D. Sammel, Dina Appleby, et al.. (2010). Evidence of a gene-environment interaction that predisposes to spontaneous preterm birth: a role for asymptomatic bacterial vaginosis and DNA variants in genes that control the inflammatory response. American Journal of Obstetrics and Gynecology. 202(4). 386.e1–386.e6. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Simpson Breakdown of academic impact, for papers by Aida Lteif Breakdown of academic impact, for papers by Dalit Modan‐Moses Breakdown of academic impact, for papers by Silvia Lai Breakdown of academic impact, for papers by Neville J. Howard Breakdown of academic impact, for papers by Hilary F. Luderer Breakdown of academic impact, for papers by Assimina Galli‐Τsinopoulou Breakdown of academic impact, for papers by Hyun Wook Chae Breakdown of academic impact, for papers by Nicola Crabtree Breakdown of academic impact, for papers by Ayşe Balat
Rankless by CCL
2026